Exagen Inc. Partners with Oregon's St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune DiseasesGlobeNewsWire • 01/04/21
Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and managementGlobeNewsWire • 11/16/20
Exagen Inc. (XGN) CEO Ron Rocca on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 InfectionGlobeNewsWire • 11/02/20
Exagen Showcases Six Scientific Presentations at ACR's First Virtual Annual Meeting in November 2020GlobeNewsWire • 10/21/20
New Data Demonstrates Economic Benefit of Exagen’s AVISE® Lupus Test for PayorsGlobeNewsWire • 10/12/20
Exagen Inc. Announces Agreement with Provider Network of America Expanding Access for AVISE® Tests to 8 Million MembersGlobeNewsWire • 09/29/20
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)GlobeNewsWire • 09/21/20
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare ConferenceGlobeNewsWire • 09/03/20
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid SyndromeGlobeNewsWire • 08/03/20
Exagen Inc. (XGN) CEO Ron Rocca on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/29/20